{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:28:01Z","timestamp":1787808481602,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bmcl.2019.126927","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T11:37:23Z","timestamp":1577101043000},"page":"126927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy"],"prefix":"10.1016","volume":"30","author":[{"given":"Xiaodi","family":"Kou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9533","key":"10.1016\/j.bmcl.2019.126927_b0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bmcl.2019.126927_b0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","article-title":"Alzheimer's disease facts and figures","volume":"14","author":"Alzheimer's Association","year":"2018","journal-title":"Alzheimer's & Dementia"},{"issue":"1","key":"10.1016\/j.bmcl.2019.126927_b0015","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1080\/14756366.2016.1256883","article-title":"Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease","volume":"32","author":"Lan","year":"2017","journal-title":"J Enzyme Inib Med Chem"},{"key":"10.1016\/j.bmcl.2019.126927_b0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejmech.2013.10.068","article-title":"Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease","volume":"71","author":"Li","year":"2014","journal-title":"Eur J Med Chem"},{"issue":"42","key":"10.1016\/j.bmcl.2019.126927_b0025","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1002\/anie.201305372","article-title":"The catalytically active copper-amyloid-Beta state: coordination site responsible for reac- tive oxygen species production","volume":"52","author":"Cassagnes","year":"2013","journal-title":"Angew Chem Inter Ed"},{"issue":"9","key":"10.1016\/j.bmcl.2019.126927_b0030","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2460","article-title":"Resolving controversies on the path to Alzheimer\u2019s therapeutics","volume":"17","author":"Selkoe","year":"2011","journal-title":"Nature Med"},{"issue":"2","key":"10.1016\/j.bmcl.2019.126927_b0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/156720509787602861","article-title":"Cholinesterase inhibitors and beyond","volume":"6","author":"Pepeu","year":"2009","journal-title":"Curr Alzheimer Res"},{"issue":"11","key":"10.1016\/j.bmcl.2019.126927_b0040","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1586\/ern.10.105","article-title":"Cholinesterase inhibitors: beyond Alzheimer's disease","volume":"10","author":"Larner","year":"2010","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"10.1016\/j.bmcl.2019.126927_b0045","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/cbdd.12580","article-title":"Design, synthesis, and biological evaluation of scutellarein carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"86","author":"Sang","year":"2015","journal-title":"Chem Biol Drug Des"},{"issue":"3","key":"10.1016\/j.bmcl.2019.126927_b0050","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10534-014-9728-5","article-title":"Homeostasis of metals in the progression of Alzheimer's disease","volume":"27","author":"Gonzalez-Dominguez","year":"2014","journal-title":"Biometals"},{"issue":"1","key":"10.1016\/j.bmcl.2019.126927_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1196\/annals.1306.012","article-title":"Redox-active metals, oxidative stress, and Alzheimer's disease pathology","volume":"1012","author":"Huang","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.bmcl.2019.126927_b0060","first-page":"2","article-title":"Multi-target-directed ligands and other therapeutic strategies in the search of a real solution for Alzheimer\u2019s disease","volume":"12","author":"Agis-Torres","year":"2014","journal-title":"Curr Neurol"},{"issue":"1","key":"10.1016\/j.bmcl.2019.126927_b0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease","volume":"3","author":"Gella","year":"2009","journal-title":"Cell Adhes Migr"},{"issue":"5","key":"10.1016\/j.bmcl.2019.126927_b0070","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/acs.jmedchem.7b01417","article-title":"Design, synthesis, and evaluation of orally bioavailable quinoline\u2013indole derivatives as innovative multi-target-directed ligands: promotion of cell proliferation in the adult murine hippocampus for the treatment of Alzheimer's Disease","volume":"61","author":"Wang","year":"2018","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2019.126927_b0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1752-153X-7-78","article-title":"Synthesis and biological evaluation of 1,3-dihydroxyxanthone mannich base derivatives as anticholinesterase agents","volume":"7","author":"Qin","year":"2013","journal-title":"Chem Cent J"},{"issue":"21","key":"10.1016\/j.bmcl.2019.126927_b0080","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.2174\/092986705774370691","article-title":"Xanthone derivatives: new insights in biological activities","volume":"12","author":"Pinto","year":"2005","journal-title":"Curr Med Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2019.126927_b0085","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1211\/jpp.61.06.0002","article-title":"Recent cancer drug development with xanthone structures","volume":"61","author":"Na","year":"2009","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"10.1016\/j.bmcl.2019.126927_b0090","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.bmcl.2012.01.068","article-title":"Identification and evaluation of apoptotic compounds from Garcinia oligantha","volume":"22","author":"Gao","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"10.1016\/j.bmcl.2019.126927_b0095","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.3390\/molecules19068317","article-title":"Xanthenedione derivatives, new promising antioxidant and acetylcholinesterase inhibitor agents","volume":"19","author":"Seca","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2019.126927_b0100","series-title":"Organic chemistry","author":"Wade","year":"2011"},{"issue":"8","key":"10.1016\/j.bmcl.2019.126927_b0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2174\/157017812802850230","article-title":"Synthesis of 1,3,6-trioxygenated prenylated xanthone derivatives as potential antitumor agents","volume":"9","author":"Lim","year":"2012","journal-title":"Lett Org Chem"},{"issue":"16","key":"10.1016\/j.bmcl.2019.126927_b0110","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1016\/j.bmc.2006.04.014","article-title":"Synthesis and pharmacological activities of xanthone derivatives as \u03b1-glucosidase inhibitors","volume":"14","author":"Liu","year":"2006","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2019.126927_b0115","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bmc.2019.01.040","article-title":"Discovery of 4'-OH-flurbiprofen Mannich base derivatives as potential Alzheimer's disease treatment with multiple inhibitory activities","volume":"27","author":"Liu","year":"2019","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2019.126927_b0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.bmcl.2019.126927_b0125","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.ejmech.2009.12.044","article-title":"Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors","volume":"45","author":"Wang","year":"2010","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2019.126927_b0130","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/14756366.2018.1430691","article-title":"Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease","volume":"33","author":"Zhu","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2019.126927_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2016.07.005","article-title":"Oxidative stress: a major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease","volume":"147","author":"Jiang","year":"2016","journal-title":"Prog Neurobiol"},{"issue":"7","key":"10.1016\/j.bmcl.2019.126927_b0140","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/aoc.3313","article-title":"Synthesis, crystal structure, electrochemistry and antioxidative activity of copper(II), manganese(II) and nickel(II) complexes containing bis (N-ethylbenzimidazol-2-ylmethyl) aniline","volume":"29","author":"Wu","year":"2015","journal-title":"Appl Organomet Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2019.126927_b0145","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-5793(78)80779-0","article-title":"Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelates: is it a mechanism for hydroxyl radical production in biochemical systems","volume":"92","author":"Halliwell","year":"1978","journal-title":"FEBS Lett"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19309102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19309102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:34:15Z","timestamp":1760772855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19309102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0960894X19309102"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126927","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"126927"}}